AvantGuard News

We’re excited to share that Ted Eveleth recently joined Marcus Arredondo on the Scales of Success podcast. This series takes an honest look at what it really takes to build, grow, and sustain successful businesses—beyond the headlines and highlight reels. Ted was honored to contribute his story to this powerful conversation.

Despite aggressive infection control protocols, Candida auris continues to defy traditional disinfection strategies—especially on high-touch hospital surfaces. But a new class of chlorine-based disinfectants may offer a long-overdue breakthrough: Avantamine, a stabilized polymer chloramine, is proving effective where others fail. In this article, we explore why C. auris has become such a resilient and costly threat—and how a next-generation technology like Avantamine is engin

Each year, fungal infections affect up to 1 billion people worldwide. While many of these infections are mild, they can become life-threatening, particularly for individuals with weakened immune systems.  Candida auris (now Candidozyma auris )  is a relatively newly identified fungal infection that has been making headlines due to its ability to spread quickly and cause serious infections. What makes C. auris truly unique is its ability to grow at human body temperature and i

Candida auris (now Candidozyma auris ) poses a serious global health threat due to its drug resistance, ability to persist on surfaces, and high mortality rates in infected patients. AvantGuard is tackling this challenge head-on with Avantamine™, a revolutionary chlorine-based compound inspired by the human immune system. Unlike traditional treatments, Avantamine™ offers a three-pronged solution: a powerful liquid antiseptic wash, a long-lasting antifungal ointment, and a re